2 weeks Ago By ABMN Staff
Parallel Advisors LLC increased its holdings in shares of IQVIA Holdings Inc. ( NYSE:IQV – Free Report ) by 3.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
The institutional investor owned 8,859 shares of the medical research company’s stock after buying an additional 296 shares during the period. Parallel Advisors LLC’s holdings in IQVIA were worth $1,873,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Other hedge funds have also recently added to or reduced their stakes in the company.
Versant Capital Management Inc raised its stake in IQVIA by 733.3% in the 2nd quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock valued at $26,000 after purchasing an additional 110 shares during the last quarter.
Opal Wealth Advisors LLC acquired a new stake in shares of IQVIA during the 2nd quarter worth about $27,000. Rise Advisors LLC acquired a new stake in shares of IQVIA during the 1st quarter worth about $31,000. Riverview Trust Co purchased a new position in IQVIA during the 1st quarter valued at about $32,000.
Finally, International Assets Investment Management LLC purchased a new position in IQVIA during the 2nd quarter valued at about $32,000. 89.62% of the stock is owned by institutional investors and hedge funds.
IQVIA Trading Up 0.1 % Shares of IQV opened at $238.70 on Monday.
The company has a market capitalization of $43.49 billion, a P/E ratio of 32.61, a P/E/G ratio of 2.
23 and a beta of 1.49. IQVIA Holdings Inc.
has a one year low of $167.42 and a one year high of $261.73.
The company has a debt-to-equity ratio of 1.80, a quick ratio of 0.85 and a current ratio of 0.
85. The stock has a 50-day moving average price of $237.98 and a 200 day moving average price of $234.
26. Analyst Upgrades and Downgrades Several equities analysts have recently issued reports on the company. StockNews.
com upgraded IQVIA from a “hold” rating to a “buy” rating in a research note on Thursday, September 5th. Truist Financial raised their target price on IQVIA from $292.00 to $300.
00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Royal Bank of Canada initiated coverage on IQVIA in a research report on Wednesday, September 4th. They set an “outperform” rating and a $275.
00 price target on the stock. Evercore ISI boosted their target price on IQVIA from $230.00 to $270.
00 and gave the company an “outperform” rating in a report on Tuesday, July 23rd. Finally, Jefferies Financial Group lowered IQVIA from a “buy” rating to a “hold” rating and dropped their target price for the company from $266.00 to $242.
00 in a report on Wednesday, July 24th. Four analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.
com, the company currently has an average rating of “Moderate Buy” and an average target price of $266.67. Get Our Latest Report on IQVIA Insiders Place Their Bets In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction that occurred on Tuesday, August 27th.
The stock was sold at an average price of $246.33, for a total transaction of $320,229.00.
Following the sale, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website .
1.60% of the stock is currently owned by company insiders. IQVIA Company Profile ( Free Report ) IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.
It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Read More Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc.
( NYSE:IQV – Free Report ). Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter .
.
